About
GRAIL develops a blood-based multi-cancer early detection test capable of screening for signals from more than 50 types of cancer before symptoms appear.
Explore GRAIL, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.